• Protease Inhibitor Cocktail for DFCP1–ATGL Assays

  2026-10-01

  Protect DFCP1–ATGL complexes and lipid-droplet proteins during cell or tissue extraction with a broad, water-soluble inhibitor mixture. This workflow pairs cold, rapid sample handling with EDTA-aware assay design for Western blotting, co-immunoprecipitation, imaging, and activity measurements.

• Potassium Channels and Renal Blood Flow in Sepsis

  2026-10-01

  The reference study examined how Kir6.1 ATP-sensitive and KCa1.1 calcium-activated potassium channel blockade changes renal vascular responses during experimental sepsis. Its central finding is that channel inhibition may have little effect at baseline yet markedly worsen renal hypoperfusion when septic animals receive norepinephrine or phenylephrine, highlighting the context-dependent risks of vasoactive treatment.

• DNP-Induced seRNA Drives NPC Metastasis

  2026-09-30

  The 2023 study identifies a carcinogen-responsive super-enhancer RNA, seRNA-NPCm, as an active regulator of nasopharyngeal carcinoma metastasis. Integrating transcriptomic, nascent-transcription, chromatin, perturbation, animal, and patient analyses, the authors connect seRNA-NPCm to an NPM1/c-Myc/NDRG1 regulatory axis.

• Streptavidin-Cy3 in Reliable Viability Assays

  2026-09-30

  Learn how Streptavidin-Cy3 (SKU K1079) can strengthen biotin-based imaging and flow cytometry workflows used alongside cell viability, proliferation, and cytotoxicity assays. The guide covers assay design, spectral selection, controls, storage, interpretation, and practical vendor comparison.

• Capless Hairpin-Protected mRNA Vaccine: Study Analysis

  2026-09-29

  Solodushko, Kim, and Fouty describe a capless mRNA architecture that combines terminal hairpins with an internal ribosomal entry site to preserve transcript stability and enable translation without a 5′ cap. When used to encode full-length Influenza A hemagglutinin and delivered in lipid-based nanoparticles, the construct induced strong antibody responses and protected mice from lethal infection.

• Trichostatin A (TSA) for Epigenetic Workflows

  2026-09-29

  Trichostatin A (TSA) enables reversible HDAC inhibition across cancer, differentiation, oxidative-stress, and bone-integration models. This practical guide connects dose planning and acetylation readouts with the AKT/Nrf2 findings from an osteoporotic implant study, helping researchers build more reproducible workflows.

• Ozone-Aged Graphene Oxide Promotes Bladder Tumors

  2026-09-28

  This study shows that ozone aging can alter graphene oxide and intensify tumor-promoting effects at exposure levels that do not produce direct acute toxicity. In bladder tumor models, ozone-aged graphene oxide increased integrin αV membrane localization and activated PI3K/AKT/mTOR and TGF-β-associated signaling, providing a mechanistic framework for more realistic environmental health assessments.

• ZCL278 Workflows for Cdc42 Signaling Research

  2026-09-28

  ZCL278 is a selective Cdc42 inhibitor for probing how Cdc42 activity shapes cell behavior, from fibroblast signaling and cell motility to neuronal growth-cone dynamics. This guide pairs practical assay workflows with a recent kidney-fibrosis study, while distinguishing pathway rationale from evidence that directly tests ZCL278.

• BMX-IN-1 and the Host Lysosome: A Causal Test

  2026-09-27

  BMX-IN-1 is a selective BMX kinase inhibitor that can help researchers test how host kinase activity affects lysosomal defense against tuberculosis. This article translates new BMX–ATP6V1E1 findings into a causal assay framework, while distinguishing pathway evidence from what a chemical probe alone can establish.

• BMAL1 Phase Separation Organizes Circadian Transcription

  2026-09-26

  Gao and colleagues identify BMAL1 as a phase-separating clock protein whose N-terminal disordered region supports dynamic condensates and recruitment of transcriptional machinery. Cell and mouse rescue experiments connect this organization to rhythmic gene expression and locomotor behavior, while phosphorylation emerges as a regulator of BMAL1 condensate formation.

• TPA, PKC Signaling, and PTC Immune Biology

  2026-09-25

  12-O-tetradecanoyl phorbol-13-acetate (TPA) offers translational researchers a way to perturb protein kinase C signaling and examine ERK/MAPK responses. Paired thoughtfully with papillary thyroid carcinoma (PTC) models, it can help test how acute signaling changes relate to tumor–macrophage communication—without being mistaken for a direct proxy for APOE biology. This article connects mechanistic rationale, experimental design, and model limitations to help researchers build more interpretable studies.

• o-Agatoxin IVA in Cortical Excitotoxicity

  2026-09-25

  Lustig, Ahern, and Greenberg tested whether blocking P/Q-type calcium channels with o-agatoxin IVA protects neuron-enriched cortical cultures from excitotoxic injury. The study found no protection under the tested conditions, showing that inhibition of glutamate release does not, by itself, establish neuroprotection.

• Recombinant Annexin V for Apoptosis Detection

  2026-09-24

  Brumatti, Sheridan, and Martin describe bacterial expression and purification of soluble recombinant annexin V, then its FITC labeling for detecting phosphatidylserine exposure by flow cytometry or fluorescence microscopy. The work provides a practical route to producing the probe and highlights an important interpretive point: annexin V detects a membrane change associated with apoptosis, not apoptosis uniquely in every experimental context.

• Zoledronic Acid: From Cell Death to Bone Biology

  2026-09-24

  Explore how Zoledronic Acid, a nitrogen-containing bisphosphonate, can be studied across cancer-cell and bone-disease models. This article focuses on experimental design, endpoint interpretation, and a carefully bounded lesson from new mechanistic research in immunology.

• Brefeldin A: From Trafficking Blockade to ER Stress

  2026-09-23

  Explore how Brefeldin A connects ER-to-Golgi trafficking disruption with protein quality control and cancer-cell stress responses—and how translational researchers can design experiments that distinguish mechanism from outcome.

8598 records 1/574 page Next 12345 下5页 Last page